BETAHISTINE-ZP betahistine dihydrochloride 16mg tablets blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

betahistine dihydrochloride, Quantity: 16 mg

Verfügbar ab:

Medis Pharma Pty Ltd

INN (Internationale Bezeichnung):

betahistine dihydrochloride

Darreichungsform:

Tablet

Zusammensetzung:

Excipient Ingredients: crospovidone; lactose monohydrate; povidone; stearic acid; colloidal anhydrous silica; microcrystalline cellulose

Verabreichungsweg:

Oral

Einheiten im Paket:

100 tablets, 25 tablets, 10 tablets

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Produktbesonderheiten:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B16 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2015-11-10